Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 2
2(50.0%)
Phase 1
1(25.0%)
N/A
1(25.0%)
4Total
Phase 2(2)
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03462030Phase 2Completed

Baked Milk Oral Immunotherapy for Cow's Milk Allergy

Role: collaborator

NCT01566890Not ApplicableCompleted

Microvascular Blood Flow in Sickle Cell Anemia

Role: collaborator

NCT03465254Unknown

Dengue Serostatus Study in the Philippines

Role: collaborator

NCT01788631Phase 2Completed

A Phase II Trial of Regadenoson in Sickle Cell Anemia

Role: collaborator

NCT01085201Phase 1Completed

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Role: collaborator

All 5 trials loaded